Laura Panjwani

Optune, a noninvasive device that delivers tumor-treating fields to the brain, had been found to improve efficacy compared to chemotherapy and is well-tolerated by patients with glioblastoma multiforme (GBM).

Due to a dramatic reduction of risk for cervical cancer in women who have received the HBV vaccine, there may be a reduction of screening for those women.

The incidence of hepatocellular carcinoma (HCC) in patients with hepatitis B is still on the rise, making screening and surveillance in this population all the more important.

Brachytherapy is one of three treatments considered standard of care for women with advanced cervical cancer, and it significantly increases the chance of survival. However, less than half of patients with this disease receive standard of care.

Dr. Sundar Jagannath discusses the benefits in progression-free survival and quality of life from newly-approved therapies for patients with multiple myeloma.

The field of breast cancer has evolved from the days of defaulting to chemotherapy for every patient, yet much work remains to individualize treatment. Though more promising novel regimens have become available, an expert urges clinicians to carefully weigh whether a particular new agent will provide a significant enough benefit to offset its associated toxicities, cost, and the time and commitment by the patient it requires.

An analysis of over 28,000 patients younger than 65 with incurable cancers found that approximately three-fourths of them received aggressive care within the last 30 days of life and one-third died in the hospital.

Androgen-deprivation therapy, while an effective treatment for prostate cancer, can result in side effects and a reduced quality of life.

Rolapitant (Varubi), which was recently approved by the FDA, has been shown to significantly reduce delayed phase CINV when used in combination with other antiemetic agents.

For patients with stage III colon cancer, drinking four or more cups of coffee per day may reduce risk of recurrence by 42% and death by 34%.

Breast cancer survivors are more likely to experience weight gain than cancer-free women of the same age and menopausal status, according to a recent study published in Cancer Epidemiology, Biomarkers & Prevention.

Nausea and vomiting associated with anticancer therapies continue to be among patients' most troubling symptoms. Findings of a clinical trial found that olanzapine demonstrated comparative benefits in relieving these symptoms.

A number of effective strategies exist for addressing hand-foot skin reaction to help ensure patients remain on their treatment with regorafenib (Stivarga).

During cancer treatments, patients are not the only ones who need care.

Early-stage cancer patients who are physically active throughout chemotherapy have a reduced risk of experiencing cognitive impairment known as "chemobrain," and are less likely to have chronic inflammation.

ASCO has updated and expanded its set of treatment and survivorship care plan (SCP) templates for oncology professionals and patients with cancer.

Huddle boards-permanent bulletin boards that display daily status and improvement plans for a workgroup-are part of the Kaizen lean production method, a rapid improvement initiative designed for businesses.

Statin use before or after a diagnosis of lung cancer may be linked to a reduced risk of death from the disease, according to findings of a recent study which found that patients who used statins in the year before a lung cancer diagnosis had a statistically significant 12% reduction in lung cancer-specific deaths.

E-cigarettes, championed by some as a smoking-cessation tool, may actually decrease the likelihood of quitting smoking, according to a recent population-based study of 1000 smokers published in The American Journal of Public Health.

Women who are at high risk of ovarian cancer are more likely to undergo preventive ovary removal if they are proactively offered genetic counseling, a new study has found.

Changing the administration schedule for gemcitabine plus nab-paclitaxel (Abraxane) from weekly to every other week significantly reduced side effects without impacting efficacy as a frontline treatment for patients with metastatic pancreatic cancer, according to a retrospective study presented at the 2015 GI Cancers Symposium.

A "watch and wait" surveillance approach may allow certain patients with rectal cancer to achieve excellent outcomes without immediate surgery, according to a retrospective review of clinical data presented at the 2015 Gastrointestinal Cancers Symposium.